In NB, a tumour that usually shows an initial response to chemotherapy but tends to relapse as drug-resistant disease, the inactivation of p53 via mutational or nonmutational mechanisms could eventually represent one of the most critical factors of therapeutic failure (Tweddle et al, 2003). Here, TP53 is linked to neuroblastoma.